Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

This program funds research to develop experimental monoclonal antibodies for preventing and treating emerging or re-emerging viral infections. It supports work that improves scientific and clinical understanding, creates candidate therapies, and enhances rapid production capacity to prepare for future epidemics or pandemics.